Besides the elucidation of the exact mechanisms that underlie the effect of Nrf2 on obesity and metabolism in general, it is important to consider which options are already available for clinical manipulation of the Keap1/Nrf2 pathway. The gene discussed is NFE2L2; the disease is obesity due to melanocortin 4 receptor deficiency.